Cargando...
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
Therapeutic monoclonal antibodies have become molecules of choice to treat autoimmune disorders, inflammatory diseases, and cancer. Moreover, bispecific/multispecific antibodies that target more than one antigen or epitope on a target cell or recruit effector cells (T cell, natural killer cell, or m...
Gardado en:
| Publicado en: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266686/ https://ncbi.nlm.nih.gov/pubmed/28184223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00038 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|